IN2014DN09962A - - Google Patents

Info

Publication number
IN2014DN09962A
IN2014DN09962A IN9962DEN2014A IN2014DN09962A IN 2014DN09962 A IN2014DN09962 A IN 2014DN09962A IN 9962DEN2014 A IN9962DEN2014 A IN 9962DEN2014A IN 2014DN09962 A IN2014DN09962 A IN 2014DN09962A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Peter Stanley Gagnon
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of IN2014DN09962A publication Critical patent/IN2014DN09962A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
IN9962DEN2014 2012-05-31 2014-11-25 IN2014DN09962A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261653913P 2012-05-31 2012-05-31
PCT/SG2013/000031 WO2013180647A1 (en) 2012-05-31 2013-01-21 Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities

Publications (1)

Publication Number Publication Date
IN2014DN09962A true IN2014DN09962A (ja) 2015-08-14

Family

ID=49673718

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9962DEN2014 IN2014DN09962A (ja) 2012-05-31 2014-11-25

Country Status (8)

Country Link
US (1) US9890205B2 (ja)
EP (1) EP2855504B1 (ja)
JP (1) JP6297029B2 (ja)
KR (1) KR20150027060A (ja)
CN (1) CN104507955A (ja)
IN (1) IN2014DN09962A (ja)
SG (1) SG11201407809QA (ja)
WO (1) WO2013180647A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2855502B1 (en) * 2012-05-31 2019-06-26 Agency For Science, Technology And Research Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
KR20150118120A (ko) 2013-02-22 2015-10-21 에이전시 포 사이언스, 테크놀로지 앤드 리서치 단백질 제제들로부터 엔도톡신들을 제거하기 위한 물질들 및 방법들
KR20150122650A (ko) * 2013-02-28 2015-11-02 에이전시 포 사이언스, 테크놀로지 앤드 리서치 상승된 전도도에서 비이온성 유기 폴리머들의 존재에서의 단백질 정제
WO2015126330A2 (en) * 2014-02-19 2015-08-27 Agency For Science, Technology And Research Fractionation method
EP3110829A4 (en) * 2014-02-27 2017-10-11 Agency for Science, Technology and Research Antibody purification process
SG11201607001PA (en) * 2014-02-27 2016-09-29 Agency Science Tech & Res Methods for reducing chromatin content in protein preparations by treatment with alkyl cations
WO2015135884A1 (en) * 2014-03-10 2015-09-17 Richter Gedeon Nyrt. Immunoglobulin purification using pre-cleaning steps
EP3149023A4 (en) * 2014-05-29 2017-11-22 Agency for Science, Technology and Research Protein Extraction Methods
CN104356211B (zh) * 2014-09-22 2017-08-29 山东信得科技股份有限公司 一种应用Triton X‑114和尿囊素去除重组蛋白质溶液中内毒素的方法
JP6824555B2 (ja) * 2015-03-31 2021-02-03 サイティバ・スウェーデン・アクチボラグ 液体クロマトグラフィーシステム、装置、および方法
EP3371302B1 (en) * 2015-11-05 2024-01-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the separation of virus compositions including depletion and purification thereof
WO2017145553A1 (ja) * 2016-02-25 2017-08-31 株式会社日立製作所 吸着材及び精製方法
JPWO2018092691A1 (ja) * 2016-11-18 2019-10-17 Jnc株式会社 抗体の精製方法
JPWO2018147393A1 (ja) * 2017-02-10 2019-11-21 三菱ケミカル株式会社 ヒトインスリン精製用分離剤及びヒトインスリンの精製方法
WO2019192877A1 (en) * 2018-04-03 2019-10-10 Merck Patent Gmbh Cex chromatography media and low salt elution of target proteins from biopharmaceutical feeds
JP2022547159A (ja) 2019-09-06 2022-11-10 ビーアイエー セパレーションズ ディー．オー．オー． 生物学的調製物のクロマチン含有量を低減する組成物及び方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0666793A (ja) * 1984-09-14 1994-03-11 Medekusu:Kk リウマチ疾患のみに特異的に発現する蛋白質に対して特異な抗体
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
SK288128B6 (sk) 1998-06-09 2013-10-02 Csl Behring Ag Process for purifying immunoglobulin G (IgG), liquid immunoglobulin product and use thereof for the preparation of a medicament
DE60028210T2 (de) 1999-07-30 2007-03-08 Genentech, Inc., South San Francisco Geladene filtrationmembranen und deren verwendungen
GB0216002D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US8034790B2 (en) * 2003-12-01 2011-10-11 Introgen Therapeutics Use of MDA-7 to inhibit pathogenic infectious organisms
BRPI0507298A (pt) * 2004-01-30 2007-07-03 Suomen Punainen Risti Veripalv processo para a produção de imunoglobulina segura a vìrus
KR101206788B1 (ko) * 2004-02-27 2012-11-30 옥타파르마 아게 정제된, 바이러스 안전한 항체 제제를 제공하는 방법
JP5553963B2 (ja) * 2004-10-22 2014-07-23 アムジエン・インコーポレーテツド 組換え抗体をリフォールディングする方法
DE602006015907D1 (de) * 2005-01-14 2010-09-16 Bayer Healthcare Llc Verfahren zur reinigung von factor vii
PL1869065T3 (pl) * 2005-03-11 2020-09-21 Wyeth Llc Sposób prowadzenia chromatografii podziałowej ze słabym wiązaniem
SG170837A1 (en) 2006-04-05 2011-05-30 Abbott Biotech Ltd Antibody purification
WO2007136327A1 (en) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab A method of producing igg
US20100234577A1 (en) * 2006-06-14 2010-09-16 Smithkline Beecham Corporation Methods for purifying antibodies using ceramic hydroxyapatite
CA2673851C (en) 2007-01-22 2016-05-03 Genentech, Inc. Polyelectrolyte precipitation and purification of proteins
CN101306200B (zh) * 2008-07-04 2011-04-06 四川远大蜀阳药业股份有限公司 静脉注射用乙型肝炎人免疫球蛋白的制备方法
SG2013061528A (en) * 2008-08-14 2015-03-30 Merck Sharp & Dohme Methods for purifying antibodies using protein a affinity chromatography
TW201030016A (en) * 2008-10-20 2010-08-16 Abbott Lab Antibodies that bind to IL-18 and methods of purifying the same
US20120282654A1 (en) * 2009-04-29 2012-11-08 Schering Corporation Antibody purification
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
WO2011088030A1 (en) * 2010-01-15 2011-07-21 Bryan William Jones Disease diagnosis and treatment using computational molecular phenotyping
GB201012599D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
EP3434346B1 (en) * 2010-07-30 2020-09-02 Medimmune, LLC Purified active polypeptides or immunoconjugates
KR20130140010A (ko) * 2010-10-20 2013-12-23 메디뮨 엘엘씨 봉입체의 가공처리 방법
CN102286099B (zh) * 2011-08-05 2014-04-09 深圳市卫光生物制品股份有限公司 静注巨细胞病毒人免疫球蛋白及其制备方法
KR20150118120A (ko) * 2013-02-22 2015-10-21 에이전시 포 사이언스, 테크놀로지 앤드 리서치 단백질 제제들로부터 엔도톡신들을 제거하기 위한 물질들 및 방법들
SG11201505192RA (en) * 2013-02-28 2015-08-28 Agency Science Tech & Res Chromatographic purification of antibodies from chromatin-deficient cell culture harvests
KR20160012975A (ko) * 2013-06-04 2016-02-03 에이전시 포 사이언스, 테크놀로지 앤드 리서치 단백질 정제 프로세스

Also Published As

Publication number Publication date
KR20150027060A (ko) 2015-03-11
EP2855504B1 (en) 2018-10-24
EP2855504A1 (en) 2015-04-08
CN104507955A (zh) 2015-04-08
SG11201407809QA (en) 2014-12-30
EP2855504A4 (en) 2015-07-29
US9890205B2 (en) 2018-02-13
JP2015519360A (ja) 2015-07-09
US20150183852A1 (en) 2015-07-02
JP6297029B2 (ja) 2018-03-20
WO2013180647A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
BR112014017614A2 (ja)
BR112014017592A2 (ja)
BR112014017646A2 (ja)
AR092201A1 (ja)
BR112014017607A2 (ja)
BR112013027865A2 (ja)
BR112014017609A2 (ja)
BR112014017673A2 (ja)
BR112014017644A2 (ja)
BR112014017647A2 (ja)
BR112014017588A2 (ja)
BR112014013184A8 (ja)
BR112014017618A2 (ja)
BR112014017630A2 (ja)
BR112014017652A2 (ja)
BR112015000982A2 (ja)
BR112014017621A2 (ja)
BR112014017622A2 (ja)
BR112014017627A2 (ja)
BR112014017623A2 (ja)
BR112014019428A2 (ja)
BR112015013813A2 (ja)
BR112014017667A2 (ja)
BR112014017951A2 (ja)
BR112014020259A2 (ja)